Department of Ophthalmology, Tokyo Medical University, 6-7-1 Nishi-shinjuku, Shinjuku-ku, Tokyo, 160-0023, Japan.
Jpn J Ophthalmol. 2022 Jul;66(4):343-349. doi: 10.1007/s10384-022-00926-z. Epub 2022 Jun 7.
To clarify the incidence and demographic characteristics of malignant eyelid tumors diagnosed in a single institute in Japan.
Retrospective, observational case series METHODS: Patients with malignant eyelid tumors diagnosed histopathologically at Tokyo Medical University Hospital between 1995 and 2019 were reviewed retrospectively. The incidence and demographic profile of malignant eyelid tumors were analyzed. The number of benign eyelid tumors diagnosed histopathologically during the same period was also counted.
A total of 412 patients with histopathologically proven malignant eyelid tumors were included. The most common malignant eyelid tumor was sebaceous carcinoma (n = 180, 44%), followed by basal cell carcinoma (n = 148, 36%), squamous cell carcinoma (n = 35, 9%), lymphoma (n = 28, 7%), Merkel cell carcinoma (n = 11, 3%) and others (n = 10, 2%). Mean age of all patients with malignant eyelid tumor at the time of diagnosis was 71.0 ± 13.0 years. For sebaceous carcinoma, the proportion of female patients was significantly higher than that of male patients (P = 0.0283) and the proportion of involvement of upper eyelid was significantly higher than that of lower eyelid (P = 0.0001). On the other hand, there was no sex predominance in basal cell carcinoma and squamous cell carcinoma. The proportion of involvement of lower eyelid was significantly higher than of upper eyelid in basal cell carcinoma (P = 0.001) and squamous cell carcinoma (P = 0.0012). There were 1433 patients with benign eyelid tumors accounting for 78% of all eyelid tumors during the study period.
Sebaceous carcinoma is the major malignant eyelid tumor in Japan and is more frequent in women than in men. Epidemiology of malignant eyelid tumors may be affected by the trend of population age structure associated with the recent population aging.
阐明在日本的一家医院诊断出的恶性眼睑肿瘤的发病率和人口统计学特征。
回顾性、观察性病例系列研究
回顾性分析了 1995 年至 2019 年期间在东京医科大学医院经组织病理学诊断为恶性眼睑肿瘤的患者。分析了恶性眼睑肿瘤的发病率和人口统计学特征。同时还统计了同期经组织病理学诊断为良性眼睑肿瘤的数量。
共纳入 412 例经组织病理学证实的恶性眼睑肿瘤患者。最常见的恶性眼睑肿瘤是皮脂腺癌(n = 180,44%),其次是基底细胞癌(n = 148,36%)、鳞状细胞癌(n = 35,9%)、淋巴瘤(n = 28,7%)、Merkel 细胞癌(n = 11,3%)和其他(n = 10,2%)。所有恶性眼睑肿瘤患者的诊断时平均年龄为 71.0 ± 13.0 岁。对于皮脂腺癌,女性患者的比例明显高于男性(P = 0.0283),且上眼睑受累的比例明显高于下眼睑(P = 0.0001)。另一方面,基底细胞癌和鳞状细胞癌没有性别优势。基底细胞癌和鳞状细胞癌的下眼睑受累比例明显高于上眼睑(P = 0.001 和 P = 0.0012)。研究期间,良性眼睑肿瘤患者有 1433 例,占所有眼睑肿瘤的 78%。
皮脂腺癌是日本主要的恶性眼睑肿瘤,女性多于男性。恶性眼睑肿瘤的流行病学可能受与人口老龄化相关的人口年龄结构趋势的影响。